CD56NK

CD56NK refers to a population of natural killer (NK) cells that express the CD56 antigen on their surface. NK cells are a type of lymphocyte, a white blood cell crucial for the innate immune system's function. They play a vital role in recognizing and eliminating virus-infected cells and tumor cells without prior sensitization. The CD56 molecule is a transmembrane protein, also known as NCAM (Neural Cell Adhesion Molecule). Its presence on NK cells is a common marker used for their identification and subtyping.

NK cells are broadly categorized into two main subsets based on their CD56 expression levels: CD56 bright and CD56 dim. CD56 bright NK cells are typically found in lymphoid tissues and are characterized by lower levels of CD56 expression. They are considered more immature and possess a higher capacity for cytokine production, particularly interferon-gamma, which is important for regulating immune responses. CD56 dim NK cells are more abundant in the peripheral blood and are the primary effectors of cytotoxicity. They express higher levels of CD56 and are more potent at directly killing target cells.

The CD56 marker is not exclusive to NK cells; it can also be found on some T cells, particularly gamma delta T cells, and certain myeloid cells. However, in the context of immune cell phenotyping, CD56 in combination with other markers like CD3 (which identifies T cells) is used to definitively identify NK cells. The study of CD56NK cells is important in understanding immune surveillance, their role in various diseases including infections and cancers, and their potential therapeutic applications.